Improved Polymer Functionality by Cross-linking with Glutaraldehyde to Achieve Controlled Drug Release

Author(s):  
John Rojas
2021 ◽  
Author(s):  
Yiguang Wu ◽  
Muhammad Shahid Riaz Rajoka ◽  
Jun Zeng ◽  
Hafiza Mahreen Mehwish ◽  
Wenli Liu ◽  
...  

Abstract Drug-loading hydrogels were prepared from O-carboxymethyl chitosan (O-CMCS) with a high degree of substitution and different deacetylation degree (DD) using acetylsalicylic acid as drug and glutaraldehyde as a cross-linking agent. Also, the DD’s effect on the controlled drug release performance of drug-loading particle was explored. The results showed that the hydrogels and particles were prepared from 5 g of O-CMCS solution (4.0 wt.%), 2.5 g of sodium acetylsalicylate solution (8.0 wt.%), and 1.5 mL of glutaraldehyde solution (1.0 wt.%). The interior pore size of the particle (DD = 51%) was between 50 and 100µm, and its cumulative drug release ratios in the simulated gastric and intestinal juices were of the top values. The drug release of the drug-loading particle was proved to be obviously pH sensitive and it can be applied as a colonic drug.


2015 ◽  
Vol 3 (8) ◽  
pp. 1605-1611 ◽  
Author(s):  
Tiefan Huang ◽  
Lin Zhang ◽  
Huanlin Chen ◽  
Congjie Gao

A graphene oxide film was cross-linked by polyethyleneimine as a novel drug delivery system which showed excellent antibacterial performance.


2018 ◽  
Vol 68 (12) ◽  
pp. 2925-2918
Author(s):  
Gabriela Cioca ◽  
Maricel Agop ◽  
Marcel Popa ◽  
Simona Bungau ◽  
Irina Butuc

One of the main challenges in designing a release system is the possibility to control the release rate in order to maintain it at a constant value below a defined limit, to avoid exceeding the toxicity threshold. We propose a method of overcoming this difficulty by introducing the drug into liposomes, prior to its inclusion in the hydrogel. Furthermore, a natural cross linker (as is tannic acid) is used, instead of the toxic cross linkers commonly used, thus reducing the toxicity of the release system as a whole.


2018 ◽  
Vol 14 (5) ◽  
pp. 432-439 ◽  
Author(s):  
Juliana M. Juarez ◽  
Jorgelina Cussa ◽  
Marcos B. Gomez Costa ◽  
Oscar A. Anunziata

Background: Controlled drug delivery systems can maintain the concentration of drugs in the exact sites of the body within the optimum range and below the toxicity threshold, improving therapeutic efficacy and reducing toxicity. Mesostructured Cellular Foam (MCF) material is a new promising host for drug delivery systems due to high biocompatibility, in vivo biodegradability and low toxicity. Methods: Ketorolac-Tromethamine/MCF composite was synthesized. The material synthesis and loading of ketorolac-tromethamine into MCF pores were successful as shown by XRD, FTIR, TGA, TEM and textural analyses. Results: We obtained promising results for controlled drug release using the novel MCF material. The application of these materials in KETO release is innovative, achieving an initial high release rate and then maintaining a constant rate at high times. This allows keeping drug concentration within the range of therapeutic efficacy, being highly applicable for the treatment of diseases that need a rapid response. The release of KETO/MCF was compared with other containers of KETO (KETO/SBA-15) and commercial tablets. Conclusion: The best model to fit experimental data was Ritger-Peppas equation. Other models used in this work could not properly explain the controlled drug release of this material. The predominant release of KETO from MCF was non-Fickian diffusion.


2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Joseph C. Bear ◽  
P. Stephen Patrick ◽  
Alfred Casson ◽  
Paul Southern ◽  
Fang-Yu Lin ◽  
...  

Author(s):  
Suyoung Been ◽  
Jeongmin Choi ◽  
Young Hun Lee ◽  
Pil Yun Kim ◽  
Won Kyung Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document